All news

Merck KGaA buys Silence Therapeutics for

Alpha Vantage · Investing.com India · · AI-summarised by FinFlash

Merck KGaA has announced its acquisition of Silence Therapeutics for approximately

Read original source

SLN company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.